Despite an incredibly challenging quarter from a factor perspective, Q3 was another strong period for the Fund.
Morgan Stanley investor Ruchir Sharma recently noted that money poured into AI investments now accounts for about 40% of the ...
Bristol Myers Squibb is pivoting from small-molecule drugs to mRNA and gene therapies. Click here to read more about BMY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback